BMJ case reportsHumansUstekinumabFemalePsoriasisGranuloma Annulare
Generalised granuloma annulare following ustekinumab therapy for palmoplantar psoriasis.
Samuel Morriss, Jenny Nicolopoulos, Con Dolianitis
Published: 202510.1136/bcr-2025-268668
Abstract
We report the case of a woman in her 70s who developed generalised granuloma annulare (GA) after 3 years of successful ustekinumab therapy for severe palmoplantar psoriasis. Ustekinumab, an interleukin (IL)-12/23 inhibitor, was ceased as the most lik…
Preview only. Read the full abstract at the source